For example, Feng et al. (2023) evaluated the combined effect of COR with a CD47 inhibitor, observing that the combined effect increased the proportion of macrophages with an M1 phenotype while increasing the number of CD8+ T lymphocytes infiltrating the tumor [92]. The gene discussed is CD47; the disease is neoplasm.